SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-022607
Filing Date
2024-03-14
Accepted
2024-03-14 16:09:01
Documents
4
Effectiveness Date
2024-03-14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0201586-s8_protara.htm S-8 57721
2 OPINION OF SULLIVAN & CROMWELL LLP. ea020158601ex5-1_protara.htm EX-5.1 8237
3 CONSENT OF ERNST & YOUNG LLP ea020158601ex23-1_protara.htm EX-23.1 1830
4 FILING FEE TABLE ea020158601ex-fee_protara.htm EX-FILING FEES 25627
  Complete submission text file 0001213900-24-022607.txt   94672
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277931 | Film No.: 24750157
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)